151 related articles for article (PubMed ID: 1732045)
1. Basic fibroblast growth factor in human prostate cancer cells.
Nakamoto T; Chang CS; Li AK; Chodak GW
Cancer Res; 1992 Feb; 52(3):571-7. PubMed ID: 1732045
[TBL] [Abstract][Full Text] [Related]
2. Basic fibroblast growth factor and receptor expression in human ovarian cancer.
Crickard K; Gross JL; Crickard U; Yoonessi M; Lele S; Herblin WF; Eidsvoog K
Gynecol Oncol; 1994 Nov; 55(2):277-84. PubMed ID: 7959296
[TBL] [Abstract][Full Text] [Related]
3. Highly metastatic human prostate cancer growing within the prostate of athymic mice overexpresses vascular endothelial growth factor.
Balbay MD; Pettaway CA; Kuniyasu H; Inoue K; Ramirez E; Li E; Fidler IJ; Dinney CP
Clin Cancer Res; 1999 Apr; 5(4):783-9. PubMed ID: 10213213
[TBL] [Abstract][Full Text] [Related]
4. Androgen receptor protein is down-regulated by basic fibroblast growth factor in prostate cancer cells.
Cronauer MV; Nessler-Menardi C; Klocker H; Maly K; Hobisch A; Bartsch G; Culig Z
Br J Cancer; 2000 Jan; 82(1):39-45. PubMed ID: 10638964
[TBL] [Abstract][Full Text] [Related]
5. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
[TBL] [Abstract][Full Text] [Related]
6. Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity.
Siu SW; Lau KW; Tam PC; Shiu SY
Prostate; 2002 Jul; 52(2):106-22. PubMed ID: 12111702
[TBL] [Abstract][Full Text] [Related]
7. Suramin interrupts androgen-inducible autocrine loop involving heparin binding growth factor in mouse mammary cancer (Shionogi carcinoma 115) cells.
Kasayama S; Saito H; Kouhara H; Sumitani S; Sato B
J Cell Physiol; 1993 Feb; 154(2):254-61. PubMed ID: 7678839
[TBL] [Abstract][Full Text] [Related]
8. Differential growth factor production, secretion, and response by high and low metastatic variants of B16BL6 melanoma.
Blanckaert VD; Schelling ME; Elstad CA; Meadows GG
Cancer Res; 1993 Sep; 53(17):4075-81. PubMed ID: 8358737
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of the antiangiogenic ability of linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers.
Joseph IB; Isaacs JT
Cancer Res; 1997 Mar; 57(6):1054-7. PubMed ID: 9067270
[TBL] [Abstract][Full Text] [Related]
10. Effects of thyroid hormone on androgen- or basic fibroblast growth factor-induced proliferation of Shionogi carcinoma 115 mouse mammary carcinoma cells in serum-free culture.
Sumitani S; Kasayama S; Hirose T; Matsumoto K; Sato B
Cancer Res; 1991 Aug; 51(16):4323-7. PubMed ID: 1868455
[TBL] [Abstract][Full Text] [Related]
11. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
12. Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors.
Shain SA; Ke LD; Wong G; Karaganis AG
Cell Growth Differ; 1992 Apr; 3(4):249-58. PubMed ID: 1381214
[TBL] [Abstract][Full Text] [Related]
13. Differences in responsiveness of clonally derived AXC/SSh rat prostate cancer cells to secreted or prototypic mitogens.
Shain SA; Koger JD
Cancer Res; 1989 Jul; 49(14):3898-903. PubMed ID: 2786746
[TBL] [Abstract][Full Text] [Related]
14. Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF.
Gualandris A; Urbinati C; Rusnati M; Ziche M; Presta M
J Cell Physiol; 1994 Oct; 161(1):149-59. PubMed ID: 7929600
[TBL] [Abstract][Full Text] [Related]
15. Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action.
Coltrini D; Gualandris A; Nelli EE; Parolini S; Molinari-Tosatti MP; Quarto N; Ziche M; Giavazzi R; Presta M
Cancer Res; 1995 Oct; 55(20):4729-38. PubMed ID: 7553656
[TBL] [Abstract][Full Text] [Related]
16. Exogenous fibroblast growth factors maintain viability, promote proliferation, and suppress GADD45alpha and GAS6 transcript content of prostate cancer cells genetically modified to lack endogenous FGF-2.
Shain SA
Mol Cancer Res; 2004 Nov; 2(11):653-61. PubMed ID: 15561781
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction defect appears to be the cause of rat prostate cancer cell fibroblast growth factor insensitivity.
Shain SA; Lin AL; Wong G
Cell Growth Differ; 1992 Oct; 3(10):715-22. PubMed ID: 1445801
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A
Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142
[TBL] [Abstract][Full Text] [Related]
19. Effects of basic fibroblast growth factor on proliferation, the expression of osteonectin (SPARC) and alkaline phosphatase, and calcification in cultures of human pulp cells.
Shiba H; Nakamura S; Shirakawa M; Nakanishi K; Okamoto H; Satakeda H; Noshiro M; Kamihagi K; Katayama M; Kato Y
Dev Biol; 1995 Aug; 170(2):457-66. PubMed ID: 7649376
[TBL] [Abstract][Full Text] [Related]
20. Expression of prostate specific membrane antigen in androgen-independent prostate cancer cell line PC-3.
Laidler P; Dulińska J; Lekka M; Lekki J
Arch Biochem Biophys; 2005 Mar; 435(1):1-14. PubMed ID: 15680901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]